Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-16-014500
Filing Date
2016-07-28
Accepted
2016-07-27 21:56:30
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 a2229260zs-3.htm S-3 450858
2 EX-1.2 a2229260zex-1_2.htm EX-1.2 263333
3 EX-5.1 a2229260zex-5_1.htm EX-5.1 52939
4 EX-23.2 a2229260zex-23_2.htm EX-23.2 3041
5 G730660.JPG g730660.jpg GRAPHIC 20825
6 G292820.JPG g292820.jpg GRAPHIC 16574
  Complete submission text file 0001047469-16-014500.txt   823091
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-212713 | Film No.: 161788168
SIC: 2836 Biological Products, (No Diagnostic Substances)